Application of an LC-ESI-QTOF-MS method for evaluating clindamycin concentrations in plasma and prostate microdialysate of rats.
LC-ESI-QTOF-MS
clindamycin
microdialysis
prostate
Journal
Biomedical chromatography : BMC
ISSN: 1099-0801
Titre abrégé: Biomed Chromatogr
Pays: England
ID NLM: 8610241
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
19
06
2020
revised:
19
08
2020
accepted:
25
08
2020
pubmed:
28
8
2020
medline:
30
4
2021
entrez:
28
8
2020
Statut:
ppublish
Résumé
Clindamycin is used for infections caused by Gram-positive and Gram-negative anaerobic pathogens and Gram-positive aerobes. Propionibacterium acnes is an important opportunistic microorganism of the human skin and is related to prostatitis. An LC-electrospray ionization-quadrupole time-of-flight-MS method was validated for determining clindamycin concentrations in plasma and prostate microdialysate. Clindamycin separation was carried out on a C
Substances chimiques
Clindamycin
3U02EL437C
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e4977Informations de copyright
© 2020 John Wiley & Sons, Ltd.
Références
Al-Talla, Z. A., Akrawi, S. H., & Emwas, A. H. (2011). Solid state NMR and bioequivalence comparison of the pharmacokinetic parameters of two formulations of clindamycin. International Journal of Clinical Pharmacology and Therapeutics, 49(7), 469-476. https://doi.org/10.5414/CP201478
Borin, M. T., Powley, G. W., Tackwell, K. R., & Batts, D. H. (1995). Absorption of clindamycin after intravaginal application of clindamycin phosphate 2% cream. The Journal of Antimicrobial Chemotherapy, 35(6), 833-841. https://doi.org/10.1093/jac/35.6.833
Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, M., Auwaerter, P., Bolon, M. K., … Weinstein, R. A. (2013). Clinical practice guidelines for antimicrobial prophylaxis in surgery. American Society of Health-System Pharmacists, 70, 195-283. https://doi.org/10.2146/ajhp120568
Carrasco-Portugal, M. D. C., Luján, M., & Flores-Murrieta, F. J. (2008). Evaluation of gender in the oral pharmacokinetics of clindamycin in human. Biopharmaceutical Drug Disposition, 29, 427-430.
Chang, M. J., Namgung, H., Choi, H. D., Song, Y. R., Kim, S. G., Oh, J. M., & Shin, W. G. (2012). Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study. Basic & Clinical Pharmacology & Toxicology, 110(6), 504-509. https://doi.org/10.1111/j.1742-7843.2011.00842.x
Cho, S., Im, H. T., Park, W. S., Ha, Y. H., Choi, Y. W., & Lee, K. T. (2005). Simple method for the assay of clindamycin in human plasma by reversed-phase high-performance liquid chromatography with UV detector. Biomedical Chromatography, 19, 783-787. https://doi.org/10.1002/bmc.517
Fieger-Büschges, H., Schüssler, G., Larsimont, V., & Blume, H. (1999). Determination of clindamycin in human plasma by high-performance liquid chromatography using coupled columns. Journal of Chromatography. B, Biomedical Sciences and Applications, 724(2), 281-286. https://doi.org/10.1016/S0378-4347(98)00530-1
Gatti, G., Flaherty, J., Bubp, J., White, J., Borin, M., & Gambertoglio, J. (1993). Comparative study of bioavailabilities and pharmacokinetics of clindamycin in healthy volunteers and patients with AIDS. Antimicrobial Agents and Chemotherapy, 37(5), 1137-1143. https://doi.org/10.1128/AAC.37.5.1137
Girondi, N. G., Barreto, F., Pigatto, M. C., & Dalla Costa, T. (2018). Sensitive analytical method to quantify clindamycin in plasma and microdialysate samples: Application in a preclinical pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis, 153, 57-62. https://doi.org/10.1016/j.jpba.2018.02.005
Ino, H., Takahashi, N., Saenz, A. A., Wakamatsu, A., Hashimoto, H., Nakahara, N., & Hasegawa, S. (2015). Systemic exposure to benzoic acid and hippuric acid following topical application of clindamycin 1%/benzoyl peroxide 3% fixed-dose combination gel in Japanese patients with acne vulgaris. Clinical Pharmacology in Drug Development, 04, 18-24.
Konety, B. R., Somogyi, G., Atan, A., Muindi, J., Chancellor, M. B., & Getzenberg, R. H. (2002). Evaluation of intraprostatic metabolism of 1,25-dihydroxyvitamin D3 (calcitriol) using a microdialysis technique. Urology, 59(6), 947-952. https://doi.org/10.1016/S0090-4295(01)01652-1
Lasave, A. F., D-Llopis, M., Muccioli, C., Belfort, R. Jr., & Arevalo, J. F. (2010). Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months. Ophthalmology, 117, 1831-1838.
Levinson, R. S., Mitan, S. J., Steinmetz, J. I., Gattermeir, D. J., Schumacher, R. J., & Joffrion, J. L. (2005). An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations. Clinical Therapeutics, 27(12), 1894-1900. https://doi.org/10.1016/j.clinthera.2005.12.006
Li, J., Wang, N., Zhang, Z., Tian, Y., Tang, W., & Chen, Y. (2008). Pharmacokinetics and bioequivalence study of clindamycin hydrochloride formulations after single-dose administration in healthy Chinese male volunteers. Arzneimittel-Forschung, 58(07), 358-362.
Mazur, D., Schug, B. S., Evers, G., Larsimont, V., Fieger-Büschges, H., Gimbel, W., … Blume, H. H. (1999). Bioavailability and selected pharmacokinetic parameters of clindamycin hydrochloride after administration of a new 600 mg tablet formulation. International Journal of Clinical Pharmacology and Therapeutics, 37(8), 386-392.
Muller, A. E., Mouton, J. W., Oostvogel, P. M., Dörr, P. J., Voskuyl, R. A., DeJongh, J., … Danhof, M. (2010). Pharmacokinetics of clindamycin in pregnant women in the peripartum period. Antimicrobial Agents and Chemotherapy, 54(5), 2175-2181. https://doi.org/10.1128/AAC.01017-09
Na-Bangchang, K., Banmairuroi, V., Kamanikom, B., & Kiod, D. (2006). An alternative high-performance liquid chromatographic method for determination of clindamycin in plasma. The Southeast Asian Journal of Tropical Medicine and Public Health, 37(1), 177-184.
Na-Bangchang, K., Ruengweerayut, R., Karbwang, J., Chauemung, A., & Hutchinson, D. (2008). Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria. Malaria Journal, 6, 70.
Nickel, J. C., & Xiang, J. (2008). Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis. The Journal of Urology, 179, 1391-1395.
Olender, A., Radej, S., Płaza, P., Bar, K., & Maciejewski, R. (2016). Propionibacterium acnes infection associated with cancerous prostate hypertrophy. Research Letters, 126(9), 697-699.
Olsson, J., Davidsson, S., Unemo, M., Molling, P., Andersson, S., Andren, O., … Elgh, F. (2012). Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolates. APMIS, 120, 778-785.
Plaisance, K. I., Drusano, G. L., Forrest, A., TownsendJ, R. J., & Standiford, H. C. (1989). Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphate. Antimicrobial Agents and Chemotherapy, 33(5), 618-620. https://doi.org/10.1128/AAC.33.5.618
Sutcliffe, S., & Platz, E. A. (2008). Inflammation and prostate cancer: a focus on infections. Current Urology Reports, 9(3), 243.
Szultka, M., Krzeminski, R., Jackowski, M., & Buszewski, B. (2013). Simultaneous determination of selected chemotherapeutics in human whole blood by molecularly imprinted polymers coated solid phase microextraction fibers and liquid chromatography- tandem mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 940, 66-76. https://doi.org/10.1016/j.jchromb.2013.09.009
Szultka-Mlynska, M., Pomastowski, P., & Buszewski, B. (2018). Application of solid phase microextraction followed by liquid chromatography-mass spectrometry in the determination of antibiotic drugs and their metabolites in human whole blood and tissue samples. Journal Chromatogr B Analyt Technol Biomed Life Science, 1086, 153-165. https://doi.org/10.1016/j.jchromb.2018.04.013
US Food and Drug Administration. (2001). Guidance for industry, Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Center for Veterinary Medicine, Rockville, MD.
Yang, S. H., & Lee, M. G. (2007). Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability. International Journal of Pharmaceutics, 332(1-2), 17-23. https://doi.org/10.1016/j.ijpharm.2006.11.019
Yu, L. L., Chao, C. K., Liao, W. J., Twu, T. Y., Liu, C. M., Yang, T. H., & Lin, E. T. (1999). Determination of clindamycin in human plasma by liquid chromatography-electrospray tandem mass spectrometry: application to the bioequivalence study of clindamycin. Journal of Chromatography. B, Biomedical Sciences and Applications, 724(2), 287-294. https://doi.org/10.1016/S0378-4347(99)00018-3
Zeller, V., Dzeing-Ella, A., Kitzis, M., Ziza, J.-M., Mamoudy, P., & Desplaces, N. (2010). Continuous clindamycin infusion, an innovative approach to treating bone and joint infections. Antimicrobial Agents and Chemotherapy, 54, 88-92.